One of the main roles of Public Health England's (PHE) screening quality assurance service (SQAS) is to carry out formal visits to antenatal and newborn screening services. SQAS works with professional and clinical advisors when visiting laboratories providing screening tests for: …
We have updated the sickle cell and thalassaemia (SCT) screening handbook on GOV.UK.
The NHS Fetal Anomaly Screening Programme wants to know how cascade training has impacted on the knowledge and confidence of participants who discuss the offer of screening for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome with women.
We have published new guidance that describes the checks and audits needed for antenatal and newborn screening pathways.
One of the questions health professionals regularly ask us via our screening helpdesk is ‘to whom and when can screening for Down’s, Edwards’ and Patau’s syndromes be offered?’
The London screening quality assurance service recently held a forum for heads of midwifery and screening coordinators.
The NHS Infectious Diseases in Pregnancy Screening Programme has developed a template letter for trusts to use for sending screening results to women who miscarry or choose to end the pregnancy.
Key performance indicators (KPIs) measure how the NHS screening programmes are performing and aim to give a high level overview of programme quality. This blog post updates you on our latest KPI data publications.
The sickle cell and thalassaemia data collection and performance analysis report for 1 April 2016 to 31 March 2017 is out now.
Today, we have published an updated version of our leaflet 'Congenital diaphragmatic hernia (CDH): information for parents'.